# Metformin: Incomplete Data — Unable to Generate Drug Repurposing Assessment Report

---

## Single-Sentence Summary

The Evidence Pack contains a parsing error in the drug name field (original value: `"780MG METFORMIN)"`, with dosage information apparently mixed into the same field as the drug name), resulting in inability to map DrugBank ID, empty predicted indications list, and missing Singapore regulatory data. **Currently unable to generate a valid drug repurposing assessment report.**

---

## Quick Overview

| Item | Content |
|------|---------|
| Data Status | ⚠️ Drug name parsing error |
| Identified Drug | metformin (presumed, requires confirmation) |
| Predicted New Indications | None (predicted_indications is empty) |
| TxGNN Prediction Score | No data |
| Evidence Level | Cannot be assessed |
| Singapore Market Status | Not marketed (data missing, pending verification) |
| Recommended Decision | **Hold — data quality issues, input data correction needed first** |

---

## Data Quality Issues Explanation

### Drug Name Error

The `drug.inn` field value in the Evidence Pack is:

```
780MG METFORMIN)
```

This string exhibits the following anomalies:
- The prefix `780MG` is dosage information and should not appear in the INN name field
- The string ends with an unmatched closing parenthesis `)`, apparently leftover from PDF or OCR parsing
- The correct INN should be **`metformin`**

### Cascading Effects

| Impact Item | Status |
|-------------|--------|
| DrugBank ID Mapping | Failed (null) |
| MOA Data | Missing (Data Gap) |
| TxGNN Prediction | No output (predicted_indications empty array) |
| Safety Data | All missing |
| Singapore Regulatory Data | No records |

---

## Safety Considerations

All safety data are currently missing and cannot be assessed:
- Drug warnings
- Contraindications
- Drug interactions

> Please refer to the manufacturer's package insert for warnings and precautions.

---

## Conclusion and Next Steps

**Decision: Hold**

**Reason:**

The input data's drug name field contains dosage information and anomalous characters due to parsing errors, resulting in failure of the entire assessment workflow with no predicted indications or safety data available for analysis.

**The following must be completed before proceeding:**

1. **Correct drug name**: Update `drug.inn` from `"780MG METFORMIN)"` to `"metformin"` and re-run the data extraction workflow
2. **Supply DrugBank ID**: metformin's DrugBank ID is `DB00331`, which can be directly entered for re-processing
3. **Re-run TxGNN prediction**: After correcting the input, re-run the KG + DL prediction workflow to obtain predicted_indications
4. **Confirm Singapore market status**: metformin is widely used in Singapore; confirm whether HSA registration data was missed due to the naming error
5. **Supply MOA data** (DG002): Query metformin's mechanism of action from DrugBank API
6. **Supply warnings and contraindications** (DG001): Query safety data from HSA or DrugBank

---

> ⚠️ **Note**: This report cannot be fully generated due to input data quality issues. It is recommended to first resolve the data parsing errors and then resubmit the Evidence Pack.
